In Depth: A Tale of Two Verdicts in China’s Pharmaceutical Gray Market
Listen to the full version
Years after public outcry over the high cost of domestic health care prompted Beijing to reform its stance on the illicit trade of unapproved but authentic overseas drugs, the legal landscape remains fraught with glaring inconsistencies.
Following a 2019 revision of the Drug Administration Law and the 2020 rollout of the Criminal Law Amendment, unapproved imported medications are no longer automatically classified as counterfeit drugs, and selling them is no longer prosecuted as selling phony medicine.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- DIGEST HUB
Digest Hub
Back
- China's 2019 Drug Law revision and 2020 Criminal Law Amendment decriminalized unapproved authentic overseas drugs as counterfeit, but sales risk "obstructing drug administration" charges with inconsistent regional verdicts.
- Tang Lu's Indian ED pills cases dropped in Xiamen (2023) and Lanzhou (2025) via certifications, but prosecuted in Fuxin (2026).
- Yang Huan sentenced to 6.5 years in Lishui for toxic food; supplier freed in Zezhou; experts note judicial adjustment periods.
1. China's legal handling of unapproved overseas drugs, especially Indian ED pills, shows inconsistencies despite 2019 Drug Administration Law revisions and 2020 Criminal Law Amendment decriminalizing them as counterfeits [para. 1][para. 2]. Selling such drugs still risks prosecution for "obstructing drug administration" or selling "toxic and harmful food," with verdicts varying widely by region [para. 3][para. 4].
2. Examples include charges dropped in Lanzhou and Xiamen but prison for "obstructing drug administration" in Fuxin, Liaoning; a Zhejiang seller convicted of toxic food while Shanxi supplier acquitted [para. 4]. Legal scholars attribute this to local courts' adjustment periods post-new laws, creating divergent rulings [para. 5], while backlogs and appeals persist amid gradual unification [para. 6].
3. Dealer Tang Lu relies on an Ambitree (Indian firm) certification as a "lifesaving document" for two products among 62 approved ones [para. 8][para. 9]. Indian generics supply 20% of global volume and are popular in China despite slow hospital entry [para. 10]; "Indian Viagra" sells freely online without prescriptions [para. 11]. The document saved Tang twice [para. 12].
4. In 2021, Xiamen detained Tang for illegal business, but charges dropped in 2023 due to changed judicial interpretations [para. 13][para. 14]. Lanzhou arrested him in 2023 for obstructing drug administration, but after Indian Embassy verification, dropped in 2025 [para. 15][para. 16].
5. Fuxin, Liaoning arrested Tang in 2024 for counterfeit drugs, shifting to obstructing administration; indicted 2025, trial 2026 [para. 18][para. 19]. Prosecutors claimed 75 of 96 seized varieties endangered health, not marketed abroad, violating Criminal Law Article 142-1 (up to 3-7 years) [para. 20][para. 21]. 2022 Supreme Court interpretation excludes legally marketed foreign drugs [para. 22][para. 24].
6. Fuxin relied on CDSCO website lacking Tang's drugs; defense argued site's flaws for state-approved drugs, validated Ambitree cert [para. 25][para. 26][para. 27]. Tang awaits verdict [para. 28].
7. In Yang Huan's case, Zhejiang court sentenced him to 6.5 years for toxic food (320k yuan sales) despite Ambitree cert; appeal rejected evidence [para. 30][para. 32][para. 33][para. 34][para. 35]. Upline Sun Binbin acquitted in Shanxi as not food [para. 36].
8. Zhen Zhixin in Gansu got suspended 1y2m sentence for toxic food, ignored regulator update classifying as drugs; appeals ongoing amid similar cases [para. 39][para. 40][para. 41][para. 42][para. 43]. Sun Ke's sentence reduced from 5y to suspended 3y [para. 45].
9. South Korean diet pills show similar charge variances [para. 48]. Lawyer Huang secured non-prosecution, arguing foreign legal drugs remain drugs in China [para. 49][para. 50]. Expert Chen notes 2020 amendment limits to dangerous cases, now administrative violations [para. 51][para. 52][para. 53].
10. Huang outlines judicial evolution: fake/toxic → obstructing → administrative [para. 55]. Chen says learning curves cause errors, hard to reverse [para. 56]. (498 words)
- Ambitree
- Ambitree is a prominent Indian pharmaceutical company producing generic erectile dysfunction (ED) drugs. Its certification, listing 62 legally approved drugs and validated by the Indian Embassy, served as a "lifesaving document" for seller Tang Lu, leading to dropped charges in Xiamen (2023) and Lanzhou (2025). It was also used in Yang Huan's defense.
- Meituan
- Meituan, a massive Chinese e-commerce platform, is cited in court evidence where screenshots showed identical Indian ED pills listed for sale, as submitted by defendant Yang Huan's lawyer during his appeal.
- JD.com
- JD.com, a massive Chinese e-commerce platform, lists identical Indian ED drugs, as shown in screenshots submitted as evidence in Yang Huan's court case.
- PODCAST
- MOST POPULAR
Sign in with Google
Sign in with Facebook
Sign in with 财新